Under the agreement Quest with provide the South Carolina-based medical system with lab management expertise, equipment, testing, supplies, and procurement services.
Members of the FDA, CDC, and CMS, comprising the Tri-Agency Task Force for Emergency Diagnostics, will work together to quickly respond to public health needs.
Lab director Glenn George discusses trends within clinical microbiology that could set it apart from other portions of the clinical laboratory.
Quest will provide management expertise, lab equipment, supplies, procurement processes, and reference testing to Houston Medical Center and Perry Hospital.
Test volumes, revenues per test and costs per test improved during the quarter, company executives said.
The agency said its aim is to analyze the way CMS has chosen to implement PAMA and to estimate the potential financial impact to Medicare as a result of those choices.
Deck: Increases in denials from insurers, uncollectible patient balances, and reimbursement pressures negatively affected company revenues.
Changes in physician behavior around monitoring patient response to therapeutic monoclonal antibodies is increasing demand for clinical testing of these drugs.
Proficiency testing providers told CMS last year that an update to the rule, which has not been changed since 1992, is long overdue.
Mayo's diagnostic tests do not infringe upon Athena Diagnostics' patent because they use standard methods and involve "natural law," the court ruled.
PAMA, divestitures, and weather were among the factors negatively affecting revenues in the company's diagnostic division.
Opko will use the proceeds to fund R&D to further develop its diagnostics and pharmacy portfolio, and for working capital including debt repayment.
The test, for use on the Claros I Analyzer, leverages microfluidic technology in a disposable test cassette to provide results in 10 minutes or less.
Miraca Life Sciences allegedly provided free or discounted EHR systems and technology consulting services to physicians in exchange for referrals.
The non-coverage decision came despite appeals by the company following a draft non-coverage determination issued last year.
Under new ownership, the immunology and allergy testing laboratory is looking to raise its profile in the US and overseas.
The authors of CAP's practical framework for NGS testing of inherited disorders see it as a baseline for future efforts to standardize NGS testing.
Under a separate initative, the FDA would give device makers the option of demonstrating substantial equivalence to performance criteria, rather than to a predicate device.
The two-year agreement, which took effect on Jan. 1, gives Intalere members competitive pricing if they choose Medline as their primary lab distributor.
UBS initiated coverage of Quest with a Neutral raing and a $90 price target on its shares. It gave LabCorp a Buy rating and a $169 price target.